Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.79 - $30.86 $10.5 Million - $18.2 Million
588,500 New
588,500 $10.9 Million
Q1 2022

May 16, 2022

SELL
$20.94 - $27.5 $6.28 Million - $8.25 Million
-300,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$16.79 - $27.09 $4.2 Million - $6.77 Million
-250,000 Reduced 45.45%
300,000 $7 Million
Q3 2021

Nov 15, 2021

SELL
$15.78 - $24.77 $6.15 Million - $9.66 Million
-390,000 Reduced 41.49%
550,000 $9.14 Million
Q2 2021

Aug 16, 2021

BUY
$19.4 - $27.42 $18.2 Million - $25.8 Million
940,000 New
940,000 $22.9 Million
Q1 2021

May 17, 2021

SELL
$25.02 - $54.99 $13.2 Million - $29 Million
-527,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$41.04 - $56.79 $21.7 Million - $30 Million
527,600 New
527,600 $28.2 Million
Q2 2020

Aug 14, 2020

SELL
$39.26 - $52.73 $14 Million - $18.8 Million
-357,000 Closed
0 $0
Q1 2020

Jun 17, 2020

BUY
$31.65 - $46.87 $11.3 Million - $16.7 Million
357,000 New
357,000 $15.1 Million
Q1 2020

May 15, 2020

SELL
$31.65 - $46.87 $1.71 Million - $2.53 Million
-54,000 Closed
0 $0
Q4 2019

Jun 17, 2020

BUY
$36.21 - $51.4 $1.96 Million - $2.78 Million
54,000 New
54,000 $2.31 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.39B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.